J&J declares Actelion tender offer a success, sees closing in second quarter

Filed under: News |

ZURICH (Reuters) – Johnson & Johnson declared its $30 billion tender offer for Swiss biotechnology company Actelion successful on Friday, reporting it controlled 77.2 percent of the voting rights after the main offer period.

Source:: J&J declares Actelion tender offer a success, sees closing in second quarter

      

List your business in the premium web directory for free This website is listed under Human Resources Directory